One approach to do this is bytargeting pathways like IL-2 and boosting non-specific T regulatory cells.However, tolerogenic vaccinations against atherosclerosis-related antigens can beused to increase the number of certain T regulatory cells. The gene discussed is IL2; the disease is atherosclerosis.